Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulation for the Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs Due to CRPS Types I and II

NCT02800863 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02800863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TARGET: A Post-Approval Study to Evaluate Targeted SCS Spinal Cord Stimulation (SCS) Dorsal Root Ganglion (DRG) Stimulation for the Management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs Due to CRPS Types I and II
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
August 23, 2016
Completion date
September 23, 2021
Enrollment
426 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

complex regional pain syndrome (crps)